Cargando…
QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis
QiangGuYin (QGY) is a common Traditional Chinese medicine prescription for the treatment of osteoporosis. Previous clinical studies have found that QGY effectively improves bone mineral density (BMD) in postmenopausal women, but its underlying mechanism remains unclear. The osteoprotegerin (OPG)/rec...
Autores principales: | Li, Xuefei, Cui, Longkang, Chen, Wenhua, Fang, Yuan, Shen, Gaobo, Li, Zhen, Zhang, Bingbing, Wu, Lianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572595/ https://www.ncbi.nlm.nih.gov/pubmed/34754319 http://dx.doi.org/10.1155/2021/7114139 |
Ejemplares similares
-
The effect of QiangGuYin on osteoporosis through the AKT/mTOR/autophagy signaling pathway mediated by CKIP-1
por: Yuan, Yifeng, et al.
Publicado: (2022) -
Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis
por: Shi, Zhen-Yu, et al.
Publicado: (2017) -
Exploratory study of sea buckthorn enhancing QiangGuYin efficacy by inhibiting CKIP-1 and Notum activating the Wnt/β-catenin signaling pathway and analysis of active ingredients by molecular docking
por: Yuan, Yi-Feng, et al.
Publicado: (2022) -
Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
por: Zhao, Ye, et al.
Publicado: (2020) -
Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
por: Bai, Peng, et al.
Publicado: (2011)